002793.SZ
002793.SZ
CNE1000026S7
LUOXINPHARMACEUTICAL
Loading chart...

Company Profile

Luoxin Pharmaceuticals Group Stock Co., Ltd. engages in the research and development, production, and sales of pharmaceutical products in China. The company provides anti-infective active pharmaceutical ingredients(APIs), antiviral APIs, respiratory and digestive system, nervous and endocrine system, cardiovascular system, oncology, and anti-allergic APIs and intermediates, as well as antipyretic, analgesics, and anti-inflammatory APIs and intermediates. It also offers health care services. Luoxin Pharmaceuticals Group Stock Co., Ltd. was formerly known as Zhejiang Doyin Pump Industry Co., Ltd. and changed its name to Luoxin Pharmaceuticals Group Stock Co., Ltd. in April 2020. The company was founded in 1998 and is based in Linyi, China.

Related stocks

9989.HK
9989.HK • China
HEPALINK
4.03 HKD
752.61M USD 1Y -26.6%
603567.SS
603567.SS • China
HEILONGJIANG ZBD PHARMACEUTICAL
5.4 CNY
759.73M USD 1Y -53.4%
300194.SZ
300194.SZ • China
FUAN PHARM
4.03 CNY
717.42M USD 1Y -7.8%
300039.SZ
300039.SZ • China
SHANGHAI KAIBAO
5.39 CNY
843.62M USD 1Y -11.8%
600195.SS
600195.SS • China
CHINA ANIMAL HUSBANDRY INDUSTRY
6.73 CNY
1.03B USD 1Y -6%
002737.SZ
002737.SZ • China
SFPM
11.53 CNY
1.01B USD 1Y -24.8%
300485.SZ
300485.SZ • China
SCIENCE SUN
8.57 CNY
617.67M USD 1Y -24%
600829.SS
600829.SS • China
HPGC RENMINTONGTAI PHARMACEUTIC
9.52 CNY
826.06M USD 1Y +19.9%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
46.2% p.a.
Max Drawdown (5Y)
-70.2%
Sharpe Ratio (5Y)
-0.34
Beta Factor
0.26
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (46.2% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -87.4% in the extended horizon.
ende